In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract

Proteus mirabilis, associated with complicated urinary tract infection, expresses mannose‐resistant/Proteus‐like (MR/P) fimbriae. Expression of these surface structures, which mediate haemagglutination and have a demonstrated role in virulence, undergoes phase variation. By DNA sequence analysis, a 252 bp invertible element was found in the intergenic region between mrpI, the putative site‐specific recombinase gene, and mrpA, the primary structural subunit gene. The invertible segment is flanked by identical 21 bp inverted repeats and the presumptive half‐sites for recombinase binding show homology to those recognized by FimB and FimE encoded by the Escherichia colifim (Type 1 fimbriae) gene cluster. When amplified by the polymerase chain reaction (PCR) from static broth cultures expressing MR/P fimbriae, the switch region was found in both ON and OFF positions. When PCR was used to amplify agar cultures which do not express the fimbriae, the switch region was OFF only. A canonical σ70 promoter inside the invertible element drives the transcription of mrpA when in the ON position; in the OFF position it is directed away from mrpA but does not appear to drive expression of mrpI. The mrpI gene was able to confer inversion of the mrp switch region in trans from both ON to OFF and OFF to ON. To examine the position of the switch in vivo, urine, bladder, and kidneys from mice transurethrally infected with P. mirabilis were used to prepare template DNA for PCR amplification. In the absence of urolithiasis (urease‐mediated stone formation), the switch was found 100% in the ON position, a condition never observed following in vitro culture. We conclude that MR/P phase variation is regulated at the transcriptional level by the action of MrpI on an invertible element and that there is strong selective pressure for the expression of MR/P fimbriae in vivo.

[1]  H. Mobley,et al.  Proteus mirabilis urease: operon fusion and linker insertion analysis of ure gene organization, regulation, and function , 1995, Journal of bacteriology.

[2]  R. Belas,et al.  Swarming and pathogenicity of Proteus mirabilis in the urinary tract. , 1995, Trends in microbiology.

[3]  I. Blomfield,et al.  The leucine-responsive regulatory protein binds to the fim switch to control phase variation of type 1 fimbrial expression in Escherichia coli K-12 , 1994, Journal of bacteriology.

[4]  R. Russell,et al.  Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection , 1994, Infection and immunity.

[5]  H. Mobley,et al.  Proteus mirabilis MR/P fimbrial operon: genetic organization, nucleotide sequence, and conditions for expression , 1994, Journal of bacteriology.

[6]  L. Emödy,et al.  The role of swarm cell differentiation and multicellular migration in the uropathogenicity of Proteus mirabilis. , 1994, The Journal of infectious diseases.

[7]  P. Klemm,et al.  Localization of promoters in the fim gene cluster and the effect of H-NS on the transcription of fimB and fimE. , 1994, FEMS microbiology letters.

[8]  H. Mobley,et al.  Proteus mirabilis MR/P fimbriae: molecular cloning, expression, and nucleotide sequence of the major fimbrial subunit gene , 1993, Journal of bacteriology.

[9]  M. S. McClain,et al.  Lrp stimulates phase variation of type 1 fimbriation in Escherichia coli K-12 , 1993, Journal of bacteriology.

[10]  M. Gribskov,et al.  The sigma 70 family: sequence conservation and evolutionary relationships , 1992, Journal of bacteriology.

[11]  H. Mobley,et al.  Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection , 1991, Infection and immunity.

[12]  M. S. McClain,et al.  Type 1 fimbriation and fimE mutants of Escherichia coli K-12 , 1991, Journal of bacteriology.

[13]  M. S. McClain,et al.  Type 1 fimbriae mutants of Escherichia coli K12: characterization of recognized afimbriate strains and construction of new fim deletion mutants , 1991, Molecular microbiology.

[14]  P. Zunino,et al.  Antigenic and immunogenic activity of flagella and fimbriae preparations from uropathogenic Proteus mirabilis. , 1991, Canadian journal of microbiology.

[15]  H. Holthöfer,et al.  Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract , 1990, Infection and immunity.

[16]  H. Mobley,et al.  Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources. , 1990, The Journal of infectious diseases.

[17]  P. Klemm,et al.  Regulation of the phase switch controlling expression of type 1 fimbriae in Escherichia coli , 1989, Molecular microbiology.

[18]  A. Schaeffer,et al.  In vivo expression and variation of Escherichia coli type 1 and P pili in the urine of adults with acute urinary tract infections , 1989, Infection and immunity.

[19]  M. Chamberlin,et al.  Structure and function of bacterial sigma factors. , 1988, Annual review of biochemistry.

[20]  H. Mobley,et al.  Urease-positive bacteriuria and obstruction of long-term urinary catheters , 1987, Journal of clinical microbiology.

[21]  A. Siitonen,et al.  Expression of P, type-1, and type-1C fimbriae of Escherichia coli in the urine of patients with acute urinary tract infection. , 1987, The Journal of infectious diseases.

[22]  H. Mobley,et al.  Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients. , 1987, The Journal of urology.

[23]  D. Friedman,et al.  Integration host factor is required for the DNA inversion that controls phase variation in Escherichia coli. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Simons,et al.  Improved single and multicopy lac-based cloning vectors for protein and operon fusions. , 1987, Gene.

[25]  J. Abraham,et al.  Fimbrial phase variation and DNA rearrangements in uropathogenic isolates of Escherichia coli. , 1986, Molecular biology & medicine.

[26]  P. Klemm,et al.  Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. , 1986, The EMBO journal.

[27]  J. Abraham,et al.  An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[28]  U. Setia,et al.  Bacteremia in a long-term care facility. Spectrum and mortality. , 1984, Archives of internal medicine.

[29]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[30]  R. Freter,et al.  Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin , 1983, Infection and immunity.

[31]  W. Anthony,et al.  A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. , 1982, The Journal of infectious diseases.

[32]  R. Adegbola,et al.  Haemagglutinins and fimbriae of Morganella, Proteus and Providencia. , 1982, Journal of medical microbiology.

[33]  B. Eisenstein Phase variation of type 1 fimbriae in Escherichia coli is under transcriptional control. , 1981, Science.

[34]  S. Cohen,et al.  Analysis of gene control signals by DNA fusion and cloning in Escherichia coli. , 1980, Journal of molecular biology.

[35]  I. Ofek,et al.  Influence of pili on the virulence of Proteus mirabilis in experimental hematogenous pyelonephritis. , 1978, The Journal of infectious diseases.

[36]  D. Musher,et al.  Urease. The primary cause of infection-induced urinary stones. , 1976, Investigative urology.

[37]  W. Faulk,et al.  An immunocolloid method for the electron microscope. , 1971, Immunochemistry.